SWPS University
Warsaw, Masovian Voivodeship, 03-815, Poland
NCT Number: NCT07405632
The goal of this study is to determine whether supplementation with Hericium erinaceus (Lion's Mane) extract enhances selected cognitive functions in healthy, actively working, middle-aged women. We aim to investigate a broad spectrum of cognitive functions to identify which, if any, are affected both immediately and after prolonged supplementation with Hericium erinaceus extract.
Our main research questions are as follows:
1. Can Hericium erinaceus extract supplementation modify cognitive status? 2. Is there an immediate effect on cognition following a single intake of Hericium erinaceus extract? 3. Does prolonged supplementation with Hericium erinaceus extract influence cognitive functioning? 4. Which cognitive functions are affected, and will the patterns differ between immediate effects and those observed after long-term supplementation? 5. Will participants report subjective cognitive enhancement?
Our main hypotheses are as follows:
1. A single dose of Hericium erinaceus extract will produce an acute effect, improving attention 45 minutes after intake. 2. An eight-week supplementation period with Hericium erinaceus extract will produce a chronic effect, improving long-term memory. 3. The investigators will compare Hericium erinaceus extract with a placebo (a visually identical substance that contains no active ingredients) to determine whether the extract effectively enhances cognitive functioning.
Participants will:
1. Take a Hericium erinaceus extract or placebo capsule daily for 2 months. 2. Visit SWPS University for baseline assessments before beginning supplementation (T0), a follow-up assessment 45 minutes after the initial intake (T1), and additional assessments at 1 week (T2) and 2 months (T3). 3. Complete neuropsychological testing and questionnaires during the T1, T2, and T3 visits. 4. Maintain their usual dietary habits throughout the study.
Looking for future studies?
Notify Me30 year–50 year
Female
Interventional
Not applicable
Warsaw, Masovian Voivodeship, 03-815, Poland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each participant will take extract from the fruiting bodies of Lion's Mane mushroom (Hericium erinaceus; trade name: Lion's Mane Focus; manufacturer: Omyu sp. z o.o., Warsaw, Poland). Composition: mineral water, food-grade ethanol <22%, dried Lion's Mane fruiting bodies 20,000 mg. * Dosage: 1ml per day*. * Instructions: Take before 1:00 PM.*
Each participant will take placebo. Composition: mineral water, food-grade ethanol <22%, caramel food flavouring 0.2%. * Dosage: 1ml per day*. * Instructions: Take before 1:00 PM.*
Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
The old/new word recognition task is designed to assess episodic memory. It is consisted of two phases: a learning phase and a recognition phase. During the learning phase, participants viewed 30 pictures on the computer. In the recognition phase, participants were presented with 30 "old" and 30 "new" pictures in random order and were asked to determine whether each picture had been shown during the learning phase. To analyze episodic memory task we followed Macmillan and Creelman (2005) signal detection theory, where d' is the ability to discriminate between signal and noise (between old and new stimuli), H stands for the proportion of correct changes detected (hit rate), and F stands for the proportion of changes incorrectly reported (false alarm rate). d' = zH - zF
Time frame: 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
California Verbal Learning Test (CVLT) measure the verbal learning and memory. It measures how well individuals learn and recall verbal material, assessing both short-term and long-term memory. The Differentiation score measures the ability to distinguish between correct and incorrect responses. Scores range from 0 to 16, with higher scores indicating better outcome.
Time frame: 45 minutes after the first dose, and at 8 week after the start of supplementation with Hericium erinaceus extract or placebo.
Scores range from 0 to 308, with higher scores indicating better outcome.
Time frame: 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
Scores range from 0 to 308, with higher scores indicating better outcome.
Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
The Posner Cueing Task assesses visuospatial selective attention, specifically the speed and efficiency of orienting attention to a cued location. To analyze this efficiency, we calculated the cueing effect. This is defined as the difference in mean reaction time between invalidly cued trials and validly cued trials (RT invalid-RT valid). A larger cueing effect indicates a higher "cost" of disengaging attention from an incorrect location and shifting it to the correct target.
Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
The Posner Cueing Task assesses visuospatial selective attention, specifically the speed and efficiency of orienting attention to a cued location. To assess attentional orienting speed, the primary outcome is the reaction time to the target in valid trials (where the cue correctly predicts the target location). A shorter reaction time indicates faster attentional orienting to the predicted spatial location. Reaction times are measured in milliseconds.
Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
Scores range from 0 to 63, with higher scores indicating more severe depressive symptoms.
Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
Scores range from 10 to 50, with higher scores indicating greater fatigue.
Time frame: 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
A maximum time limit of 240 seconds (4 minutes) is applied.
Time frame: 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
A maximum time limit of 240 seconds (4 minutes) is applied.
Time frame: Baseline (prior to intervention), 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
Scores range from 0 to 14, with higher scores indicating better outcome.
Time frame: Baseline (prior to intervention), 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
Scores range from 0 to 14, with higher scores indicating better outcome.
Time frame: Baseline (prior to intervention), 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
Scores range from 0 to 39, with higher scores indicating better outcome.
Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
The Memory Functioning Questionnaire (MFQ) is a self-report instrument designed to assess subjective memory functioning and memory complaints. We utilized the version developed by Gilewski et al. (1990), which consists of 64 items divided into four main subscales: Frequency of Forgetting, Seriousness of Forgetting, Retrospective Functioning, and Mnemonics Usage. Higher scores on the MFQ indicate a higher level of perceived memory functioning.
Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
The Operation Span (OSPAN) task is a standard measure of working memory capacity, requiring participants to solve mathematical equations while simultaneously remembering a sequence of letters. The primary outcome measure is the capacity load, which represents the sum of all letters from sets that were recalled perfectly in their correct order. A higher capacity load score indicates a greater ability to maintain and manipulate information in the face of distraction, reflecting superior working memory capacity.
Time frame: Baseline (prior to intervention), 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.
Scores range from 0 to 100, with higher scores indicating higher subjective energy at the time of assessment.
Time frame: 45 minutes after the first dose of supplementation with Hericium erinaceus extract or placebo.
The Raven's Progressive Matrices test is used to measure the level of general intelligence, understood as fluid intelligence. It is scored on a scale from 0 to 60, with higher scores indicating better outcome.
Time frame: 45 minutes after the first dose of supplementation with Hericium erinaceus extract or placebo.
The scale ranges from 0 to 7, with higher scores reflecting greater adherence to the Mediterranean diet.
University of Social Sciences and Humanities, Warsaw
Other
The Impact of Supplementation With Hericium Erinaceus (Lion's Mane) Extract on Cognitive Functioning: A Double-blind Placebo-controlled Study
Acronym: HECOG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07683208
Attention, Gross Motor Skills
Shenzhen, Guangdong, China
View Trial DetailsNCT03143582
Attention, Learning
Hamilton, Ontario, Canada
View Trial DetailsNCT01427231
Attention, Behavior
Wageningen, Gelderland, Netherlands
View Trial DetailsNCT01075958
Attention, Behavior
Newcastle upon Tyne, Tyne and Wear, United Kingdom
View Trial Details